{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:57:41Z","timestamp":1785862661141,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1124\/jpet.107.125211","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T01:10:49Z","timestamp":1186017049000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents"],"prefix":"10.1016","volume":"323","author":[{"given":"Astrid A.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda F.","family":"Milardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn B.","family":"DeCarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Buckholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Mays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy D.","family":"Mahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Lumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.125211_bib1","doi-asserted-by":"crossref","unstructured":"Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, and Bloom SR (2005) Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 1043: 139\u2013144.","DOI":"10.1016\/j.brainres.2005.02.065"},{"key":"10.1124\/jpet.107.125211_bib2","doi-asserted-by":"crossref","unstructured":"Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM, and Kendall ES (2006) PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J Nutr 136: 195\u2013201.","DOI":"10.1093\/jn\/136.1.195"},{"key":"10.1124\/jpet.107.125211_bib3","doi-asserted-by":"crossref","unstructured":"Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, and Bloom SR (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349: 941\u2013948.","DOI":"10.1056\/NEJMoa030204"},{"key":"10.1124\/jpet.107.125211_bib4","doi-asserted-by":"crossref","unstructured":"Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, et al. (2002) Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418: 650\u2013654.","DOI":"10.1038\/nature00887"},{"key":"10.1124\/jpet.107.125211_bib5","doi-asserted-by":"crossref","unstructured":"Boey D, Sainsbury A, and Herzog H (2007) The role of peptide YY in regulating glucose homeostasis. Peptides 28: 390\u2013395.","DOI":"10.1016\/j.peptides.2006.07.031"},{"key":"10.1124\/jpet.107.125211_bib6","doi-asserted-by":"crossref","unstructured":"Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, et al. (2005) PYY3-36 as an anti-obesity drug target. Obes Rev 6: 307\u2013322.","DOI":"10.1111\/j.1467-789X.2005.00218.x"},{"key":"10.1124\/jpet.107.125211_bib7","unstructured":"Brandt G, Park A, Wynne K, Sileno A, Jazrawi R, Woods A, Quay S, and Bloom S (2004) Nasal peptide PYY3-36: phase 1 dose ranging and safety studies in healthy human subjects. ENDO 2004. The 86th Annual Meeting of the Endocrine Society; 2004 Jun 16\u201319; New Orleans, LA. The Endocrine Society, Chevy Chase, MD."},{"key":"10.1124\/jpet.107.125211_bib8","doi-asserted-by":"crossref","unstructured":"Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, and O\u2019Rahilly S (2003) Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311: 915\u2013919.","DOI":"10.1016\/j.bbrc.2003.10.089"},{"key":"10.1124\/jpet.107.125211_bib9","doi-asserted-by":"crossref","unstructured":"Chelikani PK, Haver AC, and Reidelberger RD (2005) Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146: 879\u2013888.","DOI":"10.1210\/en.2004-1138"},{"key":"10.1124\/jpet.107.125211_bib10","doi-asserted-by":"crossref","unstructured":"Cox JE and Randich A (2004) Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations. Peptides 25: 985\u2013989.","DOI":"10.1016\/j.peptides.2004.03.003"},{"key":"10.1124\/jpet.107.125211_bib11","doi-asserted-by":"crossref","unstructured":"DeCarr LB, Buckholz TM, Coish PD, Fathi Z, Fisk SE, Mays MR, O\u2019Connor SJ, and Lumb KJ (2007a) Identification of selective neuropeptide Y2 peptide agonists. Bioorg Med Chem Lett 17: 538\u2013541.","DOI":"10.1016\/j.bmcl.2006.10.007"},{"key":"10.1124\/jpet.107.125211_bib12","doi-asserted-by":"crossref","unstructured":"DeCarr LB, Buckholz TM, Milardo LF, Mays MR, Ortiz A, and Lumb KJ (2007b) A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice. Bioorg Med Chem Lett 17: 1916\u20131919.","DOI":"10.1016\/j.bmcl.2007.01.045"},{"key":"10.1124\/jpet.107.125211_bib13","doi-asserted-by":"crossref","unstructured":"Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J, and Beglinger C (2005) Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129: 1430\u20131436.","DOI":"10.1053\/j.gastro.2005.09.001"},{"key":"10.1124\/jpet.107.125211_bib14","doi-asserted-by":"crossref","unstructured":"Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, and Rudolf K (1999) BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 384: R3\u2013R5.","DOI":"10.1016\/S0014-2999(99)00650-0"},{"key":"10.1124\/jpet.107.125211_bib15","doi-asserted-by":"crossref","unstructured":"Fitzsimons TJ and Le Magnen J (1969) Eating as a regulatory control of drinking in the rat. J Comp Physiol Psychol 67: 273\u2013283.","DOI":"10.1037\/h0026772"},{"key":"10.1124\/jpet.107.125211_bib16","doi-asserted-by":"crossref","unstructured":"Halatchev IG, Ellacott KL, Fan W, and Cone RD (2004) Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145: 2585\u20132590.","DOI":"10.1210\/en.2003-1754"},{"key":"10.1124\/jpet.107.125211_bib17","doi-asserted-by":"crossref","unstructured":"Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, et al. (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271: 26315\u201326319.","DOI":"10.1074\/jbc.271.42.26315"},{"key":"10.1124\/jpet.107.125211_bib18","doi-asserted-by":"crossref","unstructured":"Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, et al. (2000a) L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem Biophys Res Commun 272: 169\u2013173.","DOI":"10.1006\/bbrc.2000.2696"},{"key":"10.1124\/jpet.107.125211_bib19","doi-asserted-by":"crossref","unstructured":"Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LH, et al. (2000b) Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141: 1011\u20131016.","DOI":"10.1210\/endo.141.3.7387"},{"key":"10.1124\/jpet.107.125211_bib20","doi-asserted-by":"crossref","unstructured":"Koegler FH, Enriori PJ, Billes SK, Takahashi DL, Martin MS, Clark RL, Evans AE, Grove KL, Cameron JL, and Cowley MA (2005) Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 54: 3198\u20133204.","DOI":"10.2337\/diabetes.54.11.3198"},{"key":"10.1124\/jpet.107.125211_bib21","doi-asserted-by":"crossref","unstructured":"Leban JJ, Heyer D, Landavazo A, Matthews J, Aulabaugh A, and Daniels AJ (1995) Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at a Y1-type receptor. J Med Chem 38: 1150\u20131157.","DOI":"10.1021\/jm00007a012"},{"key":"10.1124\/jpet.107.125211_bib22","doi-asserted-by":"crossref","unstructured":"Lumb KJ, DeCarr LB, Milardo LF, Mays MR, Buckholz TM, Fisk SE, Pellegrino CM, Ortiz AA, and Mahle CD (2007) Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice. J Med Chem 50: 2264\u20132268.","DOI":"10.1021\/jm061454v"},{"key":"10.1124\/jpet.107.125211_bib23","doi-asserted-by":"crossref","unstructured":"Mashiko S, Ishihara A, Iwaasa H, Sano H, Ito J, Gomori A, Oda Z, Moriya R, Matsushita H, Jitsuoka M, et al. (2007) A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure. Mol Pharmacol 71: 602\u2013608.","DOI":"10.1124\/mol.106.029991"},{"key":"10.1124\/jpet.107.125211_bib24","doi-asserted-by":"crossref","unstructured":"Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, and Ladenheim EE (2005) Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol 288: R384\u2013R388.","DOI":"10.1152\/ajpregu.00535.2004"},{"key":"10.1124\/jpet.107.125211_bib25","doi-asserted-by":"crossref","unstructured":"Mullins D, Kirby D, Hwa J, Guzzi M, Rivier J, and Parker E (2001) Identification of potent and selective neuropeptide Y Y1 receptor agonists with orexigenic activity in vivo. Mol Pharmacol 60: 534\u2013540.","DOI":"10.1016\/S0026-895X(24)12616-8"},{"key":"10.1124\/jpet.107.125211_bib26","doi-asserted-by":"crossref","unstructured":"Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, et al. (2005) Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 146: 5120\u20135127.","DOI":"10.1210\/en.2005-0237"},{"key":"10.1124\/jpet.107.125211_bib27","doi-asserted-by":"crossref","unstructured":"Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, Jodka CM, Parkes DG, Paterniti JR, Srivastava VP, and Young AA (2004) Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 28: 963\u2013971.","DOI":"10.1038\/sj.ijo.0802696"},{"key":"10.1124\/jpet.107.125211_bib28","doi-asserted-by":"crossref","unstructured":"Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, and Soubrie P (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345\u2013R353.","DOI":"10.1152\/ajpregu.00545.2002"},{"key":"10.1124\/jpet.107.125211_bib29","doi-asserted-by":"crossref","unstructured":"Sileno AP, Brandt GC, Spann BM, and Quay SC (2006) Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits. Int J Obes (Lond) 30: 68\u201372.","DOI":"10.1038\/sj.ijo.0803067"},{"key":"10.1124\/jpet.107.125211_bib30","doi-asserted-by":"crossref","unstructured":"Small CJ and Bloom SR (2005) The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity. Expert Opin Investig Drugs 14: 647\u2013653.","DOI":"10.1517\/13543784.14.5.647"},{"key":"10.1124\/jpet.107.125211_bib31","unstructured":"Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, et al. (2004) Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 430: 165\u2013166."},{"key":"10.1124\/jpet.107.125211_bib32","doi-asserted-by":"crossref","unstructured":"van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, and Pijl H (2004) PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53: 1949\u20131952.","DOI":"10.2337\/diabetes.53.8.1949"},{"key":"10.1124\/jpet.107.125211_bib33","doi-asserted-by":"crossref","unstructured":"Vrang N, Madsen AN, Tang-Christensen M, Hansen G, and Larsen PJ (2006) PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 291: R367\u2013R375.","DOI":"10.1152\/ajpregu.00726.2005"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.125211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:27:01Z","timestamp":1740004021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524341576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0022356524341576"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.125211","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.125211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}